BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

  • Tina Ding
  • , Jo Ledingham
  • , Raashid Luqmani
  • , Sarah Westlake
  • , Kimme Hyrich
  • , Mark Lunt
  • , Patrick Kiely
  • , Marwan Bukhari
  • , Rikki Abernethy
  • , Ailsa Bosworth
  • , Andrew Ostor
  • , Kate Gadsby
  • , Frank Mckenna
  • , Diana Finney
  • , Josh Dixey
  • , Chris Deighton

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numberkeq249a
Pages (from-to)2217-2219
Number of pages2
JournalRheumatology
Volume49
Issue number11
DOIs
Publication statusPublished - 12 Sept 2010

Keywords

  • Adalimumab
  • Adverse event
  • Anti-TNF therapies
  • British society for rheumatology
  • Drug safety
  • Etanercept
  • Guidelines
  • Infliximab
  • Rheumatoid arthritis

Cite this